Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05747716
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-28
First Post:
2023-02-18
Brief Title:
SBRT Combined With Fruquintinib Plus PD-1CTLA-4 Antibody for Third-line Treatment in mCRC
Sponsor:
Wuhan Union Hospital China
Organization:
Wuhan Union Hospital China
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-28
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-18
First Submit QC Date:
February 18 2023
Study First Post Date:
2023-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-18
Last Update Post Date:
2023-02-28
Last Update Post Date Type:
ACTUAL